These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 30901512)

  • 1. Recombinant Viral Vectors as Neuroscience Tools.
    Chen SH; Haam J; Walker M; Scappini E; Naughton J; Martin NP
    Curr Protoc Neurosci; 2019 Apr; 87(1):e67. PubMed ID: 30901512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of Viral Constructs for Neuroanatomy, Calcium Imaging, and Optogenetics.
    Chen SH; Haam J; Walker M; Scappini E; Naughton J; Martin NP
    Curr Protoc Neurosci; 2019 Apr; 87(1):e66. PubMed ID: 30883041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral Vectors for Gene Transfer.
    Chen YH; Keiser MS; Davidson BL
    Curr Protoc Mouse Biol; 2018 Dec; 8(4):e58. PubMed ID: 30485696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adeno-associated virus and lentivirus vectors: a refined toolkit for the central nervous system.
    Blessing D; Déglon N
    Curr Opin Virol; 2016 Dec; 21():61-66. PubMed ID: 27559630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in neurotropism and neurotoxicity among retrograde viral tracers.
    Sun L; Tang Y; Yan K; Yu J; Zou Y; Xu W; Xiao K; Zhang Z; Li W; Wu B; Hu Z; Chen K; Fu ZF; Dai J; Cao G
    Mol Neurodegener; 2019 Feb; 14(1):8. PubMed ID: 30736827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of Targeted Adeno-Associated Virus (AAV) Vectors for Human Gene Therapy.
    Liu Y; Siriwon N; Rohrs JA; Wang P
    Curr Pharm Des; 2015; 21(22):3248-56. PubMed ID: 26027561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant adeno-associated virus as delivery vector for gene therapy--a review.
    Lu Y
    Stem Cells Dev; 2004 Feb; 13(1):133-45. PubMed ID: 15068701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system.
    Burger C; Gorbatyuk OS; Velardo MJ; Peden CS; Williams P; Zolotukhin S; Reier PJ; Mandel RJ; Muzyczka N
    Mol Ther; 2004 Aug; 10(2):302-17. PubMed ID: 15294177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From virus evolution to vector revolution: use of naturally occurring serotypes of adeno-associated virus (AAV) as novel vectors for human gene therapy.
    Grimm D; Kay MA
    Curr Gene Ther; 2003 Aug; 3(4):281-304. PubMed ID: 12871018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Custom adeno-associated virus capsids: the next generation of recombinant vectors with novel tropism.
    Muzyczka N; Warrington KH
    Hum Gene Ther; 2005 Apr; 16(4):408-16. PubMed ID: 15871672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vectrology of adeno-associated viruses (AAV).
    Skubis-Zegadło J; Stachurska A; Małecki M
    Med Wieku Rozwoj; 2013; 17(3):202-6. PubMed ID: 24296444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting microglia with lentivirus and AAV: Recent advances and remaining challenges.
    Maes ME; Colombo G; Schulz R; Siegert S
    Neurosci Lett; 2019 Aug; 707():134310. PubMed ID: 31158432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adeno-associated virus as a gene therapy vector: strategies to neutralize the neutralizing antibodies.
    Lotfinia M; Abdollahpour-Alitappeh M; Hatami B; Zali MR; Karimipoor M
    Clin Exp Med; 2019 Aug; 19(3):289-298. PubMed ID: 31054018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Adeno-associated viral vectors: methods for production and purification for gene therapy applications].
    Mena-Enriquez M; Flores-Contreras L; Armendáriz-Borunda J
    Rev Invest Clin; 2012; 64(5):487-94. PubMed ID: 23544311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viral Vectors for Gene Therapy: Translational and Clinical Outlook.
    Kotterman MA; Chalberg TW; Schaffer DV
    Annu Rev Biomed Eng; 2015; 17():63-89. PubMed ID: 26643018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new method for recombinant adeno-associated virus vector delivery to murine diaphragm.
    Mah C; Fraites TJ; Cresawn KO; Zolotukhin I; Lewis MA; Byrne BJ
    Mol Ther; 2004 Mar; 9(3):458-63. PubMed ID: 15006614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Developments in gene delivery vectors for ocular gene therapy].
    Khabou H; Dalkara D
    Med Sci (Paris); 2015 May; 31(5):529-37. PubMed ID: 26059304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative Study of Adeno-associated Virus, Adenovirus, Bacu lovirus and Lentivirus Vectors for Gene Therapy of the Eyes.
    Kalesnykas G; Kokki E; Alasaarela L; Lesch HP; Tuulos T; Kinnunen K; Uusitalo H; Airenne K; Yla-Herttuala S
    Curr Gene Ther; 2017; 17(3):235-247. PubMed ID: 28982327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adeno-associated virus and lentivirus vectors mediate efficient and sustained transduction of cultured mouse and human dorsal root ganglia sensory neurons.
    Fleming J; Ginn SL; Weinberger RP; Trahair TN; Smythe JA; Alexander IE
    Hum Gene Ther; 2001 Jan; 12(1):77-86. PubMed ID: 11177545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insertional mutagenesis of the adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors targeted to alternative cell-surface receptors.
    Shi W; Arnold GS; Bartlett JS
    Hum Gene Ther; 2001 Sep; 12(14):1697-711. PubMed ID: 11560765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.